A decisive step toward AI/power/defense infrastructure, with a record backlog pointing to a multiyear growth cycle
AME · Earnings Call · 2026-08-04
A new thesis in the "beginning stages"
AMETEK's Q2 2026 was a standout by any headline: record sales of $2.04B (up 15%, 10% organic), record EPS of $2.09 (up 17%), free cash flow up 37% to $452M, and full-year guidance raised to $8.20–$8.30. But the more consequential change is the narrative. CEO Dave Zapico has recast the company — once a diversified industrial — into a concentrated bet on a coherent, secular theme that stitches together its historically disparate businesses.
I believe we're in the beginning stages of a multiyear infrastructure build-out, and we're incredibly well positioned.
This framing is genuinely new. In AME's own keyword trajectory, power grid has leapt from rank ~21 in mid-2025 to rank 2 this quarter (momentum 218), joined by AI infrastructure and multiyear infrastructure — all fresh at the top of a quarter where the company explicitly quantified the opportunity. When asked how much of the business touches data-center/AI buildout, Zapico bundled it with two other secular drivers: “I put that whole bucket together, and it's about half of our business.” — David Zapico, Chairman and Chief Executive Officer · 2026-08-04 (Data center itself is "not big enough to report on a specific segment," but the halo is broad.)
The proof points are concrete, not aspirational. RTDS Technologies — the real-time power-simulation leader — received a key order from a data-center hyperscaler to derisk a broader build-out. Zygo's precision optics and 3D metrology are designed into leading semiconductor platforms for AI and next-gen computing. And MedTech strength at Paragon Medical (orthopedics, drug-delivery systems) continues to outpace the market. The keyword Defense modernization — flagged across the global tape this quarter — is repeatedly described as "nondiscretionary," while the super cycle in commercial aerospace adds a fourth pillar.
Orders: the leading indicator that changed
If the framing is aspiration, the orders data is the substance. Overall orders hit a record $2.3B, up 28%, with organic orders up 25% — following 22% organic growth in Q1. Book-to-bill was 1.12, and backlog reached a record $4.11B, up 21% from year-end, with roughly 80% scheduled to ship within 12 months. Most tellingly, “June was the strongest month for orders in the quarter in all time” — David Zapico, Chairman and Chief Executive Officer · 2026-08-04, and July orders remained "very good." This builds on a consistent cadence: in the April call, Zapico noted “March was an all-time record of any quarter for orders at AMETEK” — David Zapico, Chairman and Chief Executive Officer · 2026-04-30 — so this is acceleration, not a one-off spike.
The breadth is notable: all four market segments grew organically, with EMG (Aerospace, Defense, MedTech, Automation) organic orders up 35% and every division up double-digits. Zapico acknowledged "a bit of a lumpy nature to the order," yet the record June and strong July point to sustainability. In the prior October call, he had described Process as the laggard waiting to turn: “I think that as that business comes back sometime in next year... we have a business that's leveraged to succeed because the cost structure is really well controlled.” — David Zapico, Chairman and Chief Executive Officer · 2025-10-30 That turn is now visible — Process delivered high-teens overall sales with high-single-digit organic growth, and the company raised its full-year process outlook to mid-single digits. The Growth Model keyword has climbed to #1 in the company's own trajectory, and the order book is now the clearest evidence it is working.
The $5B strategic pivot: Indicor
The single biggest change is the pending acquisition of Indicor Instrumentation — a $5B deal, by far the largest in AMETEK's history, expected to close in H2 2026. CFO Dalip Puri: “Following the closing of the acquisition, we will continue to have substantial financial capacity, including approximately $2.5 billion of cash and available credit facilities to support our growth initiatives and strategic acquisitions.” — Dalip Puri, Executive Vice President and Chief Financial Officer · 2026-08-04
Indicor brings "a higher profitable recurring revenue stream of 50% of revenue," and management confirmed 10–12% cost synergies (global sourcing, shared services, facility rationalization). This is a structural shift toward recurring precision-instrumentation revenue — consistent with the AI/power theme — and the balance sheet supports it: net debt-to-EBITDA is just 0.6x after repayment, and AME renewed its revolver to $3.5B with a 2031 maturity. The company's net debt position of roughly -$0.6B is far below its history, giving it dry powder exactly when infrastructure-linked M&A is scarce. Effective net cash improved 45% year-over-year to −$581M — a fortuitous position ahead of a record acquisition.
Standing apart on tariffs — and on execution
A notable contrast with the sector: the global earnings tape this quarter is crowded with IEEPA/tariff refunds, yet when asked directly, AME confirmed no tariff refunds hit its margins. Price, not refunds, offsets inflation and tariffs — a reflection of a differentiated, mission-critical portfolio with high switching costs. It's also a reminder that the margin expansion is real, not an accounting artifact. Operating margins reached 26.7% in the latest quarter, with EMG core margins up a striking 290 basis points on Paragon leverage. Free-cash-flow conversion of 111% and working-capital improvement of 220 basis points round out a disciplined quarter.
The stock's reaction tells the same story: AME reached an all-time high of $258.52 eight days after the report, and has since pulled back ~7% — a textbook consolidation after a strong confirmation. With orders, guidance, and balance-sheet capacity all pointing the same way, this is a large-cap compounder deliberately repositioning for a multiyear infrastructure cycle, and the market is beginning to price it accordingly.